Head-to-head · WeighScore
CVS MinuteClinic vs Omada Health
The verdict
CVS MinuteClinic takes it — 61.7/100 to 55.6/100.
CVS MinuteClinic grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CVS MinuteClinic® Weight Loss Program offers FDA-approved brand-name GLP-1 medications (semaglutide, tirzepatide, liraglutide/Saxenda) at in-clinic or virtual visits — no compounded products.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | CVS MinuteClinic | Omada Health |
|---|---|---|
| WeighScore | 61.7/100 | 55.6/100 |
| Grade | C | C |
| Scorecard rank | #287 | #435 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #287 · C
Strengths
- Brand-name GLP-1s (Wegovy, Zepbound, Saxenda) — no compounded products prescribed
- Walk-in clinic visits; no appointment necessary at MinuteClinic locations
- Insurance accepted; GLP-1 copay as low as $25 with coverage
- $49 virtual visit to start — no subscription or monthly fee
- Board-certified providers with follow-up care, nutritional counseling, injection training
Where it loses points
- Brand-name only — compounded GLP-1 not available at MinuteClinic
- GLP-1 prescribing not available in all states
- Medication cost billed separately at pharmacy; cash-pay GLP-1 from $149/month with coupon
- Requires in-person clinic visit or virtual consult — not home-delivery telehealth
Graded #435 · C
Strengths
- Added GLP-1 prescribing and medication management in late 2025
- Clinicians trained in obesity care, available in all 50 states
- Behavioral support wrapped before, during and after treatment
- GLP-1 Flex Care adds a cash-pay medication pathway in 2026
- Publicly traded, evidence-based virtual care platform
Where it loses points
- Core program distributed via employers and health plans, limited cash-pay
- GLP-1 prescribing is a recent addition still scaling
- GLP-1 Flex Care only rolling out to employers later in 2026
- No transparent published price for the core member program
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.